Last update 08 May 2025

Suzhou Maidixian Pharmaceutical Technology Co., Ltd.

Private Company|2008|Jiangsu Sheng, China

Overview

Tags

Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PDE5A(Phosphodiesterase 5A)1

Related

4
Drugs associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Xiongdenafil Citrate
Target
PDE5A
Mechanism
PDE5A inhibitors
Active Org.
Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Originator Org.
Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Active Indication
Erectile Dysfunction
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
Triptolide/Brazilin/Borneol
Target-
Mechanism
Immunosuppressants
Active Org.-
Originator Org.
Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Active Indication-
Inactive Indication
Systemic Lupus Erythematosus
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
MDX-2
Target
FASN
Mechanism
FAS inhibitors
Active Org.-
Originator Org.
Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
CTR20191491
/ Not yet recruitingPhase 1
评估枸橼酸雄地那非片在健康男性志愿者中的安全、耐受性和药代动力学研究
[Translation] A study to evaluate the safety, tolerability and pharmacokinetics of androgen citrate tablets in healthy male volunteers
100 Clinical Results associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Deals associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Maidixian Pharmaceutical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
3
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Xiongdenafil Citrate
 ( PDE5A )		Erectile Dysfunction
More
Phase 1
MDX-1
 ( Raf kinase x VEGFR )		Neoplasms
More
Pending
Triptolide/Brazilin/Borneol
Systemic Lupus Erythematosus
More
Pending
MDX-2
 ( FASN )		Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free